Tamoxifen is a cornerstone of HR+ treatment, approved for both pre- and post-menopausal patients to reduce recurrence risk.
Drugs like Anastrozole (Arimidex) , Letrozole (Femara), and Exemestane (Aromasin) are primarily for postmenopausal women. They block the aromatase enzyme, which is necessary for making estrogen in the body. 2. Targeted Therapies breast cancer drugs
Hormone therapies are used for cancers that are hormone receptor-positive (HR+), meaning they use estrogen or progesterone to grow. These drugs either lower hormone levels or block receptors on cancer cells. Tamoxifen is a cornerstone of HR+ treatment, approved
Targeted drugs recognize specific markers, typically proteins, that help cancer cells grow and spread. breast cancer drugs